pubmed-article:11691824 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C0032854 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C1561558 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:11691824 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:11691824 | pubmed:issue | 21 | lld:pubmed |
pubmed-article:11691824 | pubmed:dateCreated | 2001-11-5 | lld:pubmed |
pubmed-article:11691824 | pubmed:abstractText | Carbonic anhydrase-9 (CA9), a transmembrane enzyme with an extracellular active site, is involved in the reversible metabolism of the carbon dioxide to carbonic acid. Up-regulation of CA by hypoxia and the hypoxia-inducible factor (HIF) pathway has been recently postulated (Wykoff et al. Cancer Res., 60: 7075-7083, 2000). In the present study we examined the expression of this enzyme in non-small cell lung cancer. Of 107 cases analyzed, 39 (36.4%) had strong membrane/cytoplasmic expression of CA9 and were grouped as positive. The staining was confined around areas of necrosis, and a significant association of CA9 expression with the extent of necrosis was noted (P = 0.004). Nevertheless, 38 of 74 cases with focal or extensive necrosis did not express CA9. CA9 expression was more frequent in the squamous cell histology (P = 0.001) and with advanced T stage (P = 0.009). A significant coexpression of CA9 with platelet-derived endothelial cell growth factor and basic fibroblast growth factor receptor expression was noted. Double staining of CA9 with anti-CD31 monoclonal antibody revealed an overall higher microvessel density in the areas expressing CA9 than in negative areas (P = 0.0005). Thirty-one of 38 CA9-positive cases were positive for HIF1a/HIF2a, but HIF positivity was a more common event (68 of 107) and their patterns of expression were diffuse (not confined in the necrotic areas). A direct association of CA9 expression with epidermal growth factor receptor, c-erbB-2, and MUC1 expression was also noted (P < 0.04). Survival analysis showed that CA9 expression is related to poor prognosis. CA9 expression in tumors with low vascularization defined a prognosis similar to the one of patients with highly angiogenic tumors. Multivariate analysis revealed that CA9 expression is a significant prognostic factor independent of angiogenesis. We conclude that CA9 is an important molecule in non-small cell lung cancer, the up-regulation of which occurs in highly hypoxic/necrotic regions of the tumors. The expression of CA9 is linked to the expression of a constellation of proteins involved in angiogenesis, apoptosis inhibition, and cell-cell adhesion disruption, which explains the strong association of CA9 with poor outcome. | lld:pubmed |
pubmed-article:11691824 | pubmed:language | eng | lld:pubmed |
pubmed-article:11691824 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11691824 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11691824 | pubmed:month | Nov | lld:pubmed |
pubmed-article:11691824 | pubmed:issn | 0008-5472 | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:HarrisA LAL | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:GatterK CKC | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:PastorekJJ | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:SivridisEE | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:Giatromanolak... | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:KoukourakisM... | lld:pubmed |
pubmed-article:11691824 | pubmed:author | pubmed-author:WykoffC CCC | lld:pubmed |
pubmed-article:11691824 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11691824 | pubmed:day | 1 | lld:pubmed |
pubmed-article:11691824 | pubmed:volume | 61 | lld:pubmed |
pubmed-article:11691824 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11691824 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11691824 | pubmed:pagination | 7992-8 | lld:pubmed |
pubmed-article:11691824 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:meshHeading | pubmed-meshheading:11691824... | lld:pubmed |
pubmed-article:11691824 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11691824 | pubmed:articleTitle | Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. | lld:pubmed |
pubmed-article:11691824 | pubmed:affiliation | Tumour and Angiogenesis Research Group, Department of Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis 68100, Greece. targ@her.forthnet.gr | lld:pubmed |
pubmed-article:11691824 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11691824 | lld:pubmed |